Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Canada’s Controversial Pricing Guidelines Suspended

11 Jan 2023

• By Francesca Bruce

Pigg Bank Canada — Canada to rethink drug pricing guidelines • Source: Shutterstock

Related Content

Industry Calls For Canadian Pricing Guideline Consultation To Be Suspended

01 Dec 2022

'Status Quo' Interim Pricing Guidance Now In Force In Canada

25 Aug 2022

Canada Pulls Controversial Pricing Measures

04 May 2022

Additional Topics

Canada Market Access Policy Pricing Debate Pricing Strategies Regulation BioPharmaceutical

More from Canada

More from North America

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.